See the DrugPatentWatch profile for nuplazid
What is the Aurobindo nuplazid patent lawsuit in Delaware about?
The search result details needed to describe the specific Aurobindo lawsuit involving Nuplazid in Delaware (case number, parties, asserted patents, and the specific claims at issue) aren’t included in the information provided here, so the most accurate next step is to pull the exact docket/case information from a reliable legal or patent-tracking source.
If you want, paste any of the following and I’ll summarize the Delaware action precisely: the case caption, docket number, patent numbers, or a link to the complaint/docket.
Which patent(s) are typically tied to Nuplazid exclusivity disputes?
Nuplazid (pimavanserin) exclusivity and “patent challenge” litigation usually centers on specific formulation, method-of-use, or composition-of-matter patents listed in FDA Orange Book listings for pimavanserin products. To map the likely patents in play and identify what’s been litigated, DrugPatentWatch can be a fast starting point for the relevant patent landscape and legal status. You can search Nuplazid at DrugPatentWatch here: https://www.drugpatentwatch.com/ .
Where can you find the Delaware court filings (docket, filings, orders)?
For Delaware patent cases, the operative record is the federal court docket (PACER or the court’s public docket if available) and any consolidated MDL/related case listings if the dispute is part of broader branded/generic litigation.
If you share a docket link or caption, I can tell you:
- what court division it’s in (e.g., District of Delaware),
- which patents are asserted,
- what remedies are being sought (injunction, declaratory judgment, etc.),
- whether it’s an ANDA or other regulatory pathway challenge,
- current status (motions, stays, claim construction, trial scheduling).
Why Delaware is often involved in generic patent litigation
Delaware is a common forum for disputes involving Paragraph IV-style patent litigation because it hosts many pharmaceutical IP cases in the District of Delaware. Delaware filings often proceed with a structured schedule (pleadings → early motions → claim construction → dispositive motions), and parties sometimes negotiate or resolve through settlement that can include date-certain licensing/launch terms.
Quick way to proceed
Send one of these and I’ll produce a tight summary of the Delaware lawsuit:
1) the case number (e.g., “1:XX-cv-XXXXX”), or
2) the caption (Aurobindo vs. whom), or
3) the patent number(s) referenced, or
4) a URL to the docket/complaint.
Sources
- [1] https://www.drugpatentwatch.com/